Business
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. "Jack" Kenny to its Board of Directors
FORT MYERS, Fla., December 30, 2025--NeoGenomics announced the appointment of John P. "Jack" Kenny to its Board of Directors.
About this update from Neogenomics, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2390,"height":984,"url":"https://media.zenfs.com/en/business-wire.com/b5f4eed90264f98c882d5b7741dba454"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/DnbrNz5Pjk_yNZ07uuSJlQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM5NTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/b5f4eed90264f98c882d5b7741dba454","width":960,"height":395},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/RRC7WnlEKshajGeIiZkGOw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD05ODg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/b5f4eed90264f98c882d5b7741dba454","width":1200,"height":494}},"lazy":false},{"type":"text","content":"FORT MYERS, Fla., December 30, 2025--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the appointment of diagnostics and lab services industry veteran John P. "Jack" Kenny to its Board of Directors. Mr. Kenny is filling the seat vacated by Alison Hannah, MD, who is rotating off the Board after more than ten years of dedicated service.","length":446,"tagName":"p"},{"type":"text","content":"Mr. Kenny brings to the NeoGenomics Board over three decades of diverse executive, commercial, and operational experience and a track record of success in the diagnostics and lab services businesses. He most recently served as President, Chief Executive Officer and Board Director of Meridian Bioscience, a fully integrated life science company that develops, manufactures and distributes a broad range of innovative diagnostic products and critical raw materials for immunoassay and molecular testing companies. Meridian, which formerly traded on the NASDAQ exchange under the ticker "VIVO," was taken private in January 2023.","length":637,"tagName":"p"},{"type":"text","content":""We are very excited to welcome Jack to the NeoGenomics Board," said Lynn Tetrault, Chair of the Board of NeoGenomics. "His vast experience building winning cultures and leading high performance commercial teams will serve us well as we pursue significant emerging opportunities in the next generation of cancer testing, notably NGS and MRD. I look forward to his insights and guidance."","length":407,"tagName"...